NYSE - Nasdaq Real Time Price USD

U.S. Physical Therapy, Inc. (USPH)

97.18 -0.54 (-0.55%)
As of 1:01 PM EDT. Market Open.

Earnings Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts 4444
Avg. Estimate 0.810.762.863.19
Low Estimate 0.740.722.753.05
High Estimate 0.890.832.943.36
Year Ago EPS 0.760.622.562.86

Revenue Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts 3333
Avg. Estimate 162.86M162.48M647.2M684.61M
Low Estimate 160M161M640M665M
High Estimate 165.35M164.9M655.5M703.1M
Year Ago Sales --150.01M604.8M647.2M
Sales Growth (year/est) --8.30%7.00%5.80%

Earnings History

CURRENCY IN USD 6/30/2023 9/30/2023 12/31/2023 3/31/2024
EPS Est. 0.750.620.570.56
EPS Actual 0.760.620.590.51
Difference 0.0100.02-0.05
Surprise % 1.30%0.00%3.50%-8.90%

EPS Trend

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.810.762.863.19
7 Days Ago 0.810.762.863.19
30 Days Ago 0.80.692.773.09
60 Days Ago 0.80.692.773.09
90 Days Ago 0.790.662.683.01

EPS Revisions

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days 112--
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD USPHIndustrySectorS&P 500
Current Qtr. 6.60%----8.90%
Next Qtr. 22.60%----11.40%
Current Year 11.70%----5.70%
Next Year 11.50%----12.60%
Next 5 Years (per annum) 9.10%----11.43%
Past 5 Years (per annum) -2.45%------

Research Analysis

Analyst Price Targets

120.00
121.38 Average
97.18 Current
122.50 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains Barrington Research: Outperform to Outperform 5/9/2024
Maintains JP Morgan: Overweight to Overweight 3/13/2024
Maintains Barrington Research: Outperform to Outperform 3/1/2024
Maintains Barrington Research: Outperform to Outperform 1/3/2024
Maintains JP Morgan: Overweight to Overweight 11/17/2023
Maintains Barrington Research: Outperform to Outperform 11/9/2023

Related Tickers